Pyruvate Kinase Deficiency Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AGIO | B | Agios Pharmaceuticals, Inc. | -2.09 | |
RCKT | D | Rocket Pharmaceuticals, Inc. | -1.34 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Pyruvate Kinase Deficiency stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
GNOM | D | Global X Genomics & Biotechnology ETF | 3.5 | |
BBP | D | BioShares Biotechnology Products Fund | 2.67 | |
HELX | D | Franklin Genomic Advancements ETF | 1.96 | |
XBI | D | SPDR S&P Biotech ETF | 1.71 | |
WDNA | D | WisdomTree BioRevolution Fund | 1.7 |
Compare ETFs
Related Industries:
Biotechnology
- Pyruvate Kinase Deficiency
Pyruvate kinase deficiency is an inherited metabolic disorder of the enzyme pyruvate kinase which affects the survival of red blood cells. Both autosomal dominant and recessive inheritance have been observed with the disorder; classically, and more commonly, the inheritance is autosomal recessive. Pyruvate kinase deficiency is the second most common cause of enzyme-deficient hemolytic anemia, following G6PD deficiency.
Popular Now
Recent Comments
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
From the Blog
Featured Articles